Stealth BioTherapeutics Corp. ADS
MITO
MITO was delisted on the 15th of November, 2022.
13 hedge funds and large institutions have $638K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
5% more capital invested
Capital invested by funds: $607K → $638K (+$30.9K)
13% less funds holding
Funds holding: 15 → 13 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.2K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$15.7K |
| 3 |
Citigroup
New York
|
+$4.05K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.22K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$16K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$13K |
| 3 |
Renaissance Technologies
New York
|
-$7.08K |
| 4 |
Two Sigma Advisers
New York
|
-$5.95K |
| 5 |
Millennium Management
New York
|
-$1.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IC
1
Ikarian Capital
Dallas,
Texas
| $350K | +$15.7K | +23,275 | +5% |
|
|
BBHC
2
Brown Brothers Harriman & Co
New York
| $123K | – | – | – |
|
|
BFM
3
Boothbay Fund Management
New York
| $34K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $34K | +$17.2K | +25,474 | +109% |
|
|
5
Renaissance Technologies
New York
| $33K | -$7.08K | -10,473 | -18% |
|
|
6
Millennium Management
New York
| $27K | -$1.04K | -1,542 | -4% |
|
|
7
Two Sigma Advisers
New York
| $11K | -$5.95K | -8,800 | -35% |
|
|
8
Envestnet Asset Management
Chicago,
Illinois
| $10K | +$1.22K | +1,808 | +15% |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $5K | +$1K | +1,482 | +29% |
|
10
Morgan Stanley
New York
| $4K | – | – | – |
|
|
11
Citigroup
New York
| $4K | +$4.05K | +6,000 | New |
|
|
AA
12
AlphaMark Advisors
Ft. Wright,
Kentucky
| $2K | – | – | – |
|
13
UBS Group
Zurich,
Switzerland
| $1K | +$738 | +1,092 | +224% |
|
|
GSC
14
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$16K | -18,927 | Closed |
|
|
15
Citadel Advisors
Miami,
Florida
| – | -$13K | -16,213 | Closed |
|
MITO Hedge Fund Activity: Q1 2022 in Review
13 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q1 2022, worth a combined $638K — up 5.1% from $607K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MITO and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $17.2K. The largest seller was Ground Swell Capital, exiting entirely with an estimated $16K sold.
- 13 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q1 2022, down from 15 in Q4 2021.
- Funds reported $638K of Stealth BioTherapeutics Corp. ADS stock for Q1 2022, up 5.1% quarter-over-quarter.
- 1 fund opened new Stealth BioTherapeutics Corp. ADS positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest Stealth BioTherapeutics Corp. ADS buyer in Q1 2022 was Geode Capital Management, an estimated $17.2K added.
- The largest Stealth BioTherapeutics Corp. ADS seller in Q1 2022 was Ground Swell Capital, an estimated $16K sold.
Based on aggregated 13F filings for Q1 2022.